ZOLEDRONIC ACID IN OSTEOPOROSIS SECONDARY TO MASTOCYTOSIS

被引:0
|
作者
Idolazzi, L. [1 ]
Zanotti, R. [2 ]
Artuso, A. [2 ]
Tripi, G. [1 ]
Perbellini, O. [2 ]
Viapiana, O. [1 ]
Gatti, D. [1 ]
Bonifacio, M. [2 ]
Rossini, M. [1 ]
Adami, S. [1 ]
机构
[1] Univ Verona, Rheumatol Unit, Dept Med, I-37100 Verona, Italy
[2] Univ Verona, Hematol Unit, Dept Med, I-37100 Verona, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P466
引用
收藏
页码:S329 / S330
页数:2
相关论文
共 50 条
  • [31] Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis
    Dhillon, Sohita
    DRUGS, 2016, 76 (17) : 1683 - 1697
  • [32] OSTEOPOROSIS IN MASTOCYTOSIS
    REINER, M
    OLAH, A
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, : 23 - 23
  • [33] MASTOCYTOSIS AND OSTEOPOROSIS
    WATTS, RA
    SCOTT, DGI
    CRISP, AJ
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 (10): : 715 - 715
  • [34] MASTOCYTOSIS AND OSTEOPOROSIS
    MULLIER, JP
    KUTNOWSKI, M
    FUTERAL, B
    BAST, CD
    VERBANCK, M
    ACTA CLINICA BELGICA, 1979, 34 (03): : 158 - 164
  • [35] Zoledronic acid and secondary prevention of fractures
    Calis, Karim Anton
    Pucino, Frank
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18): : 1861 - 1862
  • [36] Osteoporosis in mastocytosis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S117 - S117
  • [37] Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis
    Procianoy, F.
    Procianoy, E.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (06) : 1057 - 1058
  • [38] Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis
    F. Procianoy
    E. Procianoy
    Osteoporosis International, 2010, 21 : 1057 - 1058
  • [39] CLINICAL PROFILE OF PATIENTS WITH OSTEOPOROSIS TREATED WITH ZOLEDRONIC ACID
    Tabti, E.
    Drici, Z.
    Chiali, S.
    Bestaoui, H.
    Lounici, A.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S645 - S645
  • [40] Intravenous zoledronic acid: What are the indications for male osteoporosis?
    Maricic M.
    Current Osteoporosis Reports, 2010, 8 (1) : 4 - 9